Position in EXEL
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$5,431,967
+$5,187,494 QoQ
Shares Held
99,834
+1651.5% QoQ
Ownership
0.040%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#164
of 739 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WINTON GROUP Ltd holds $97,029,578 across 91 Biotechnology names. EXEL ranks #3 (5.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
254,408 | $28,839,690 | |
| 2 | FTRE |
Fortrea Holdings Inc.
|
389,155 | $6,771,297 | |
| 3 | EXEL |
Exelixis, Inc.
This page
|
99,834 | $5,431,967 | |
| 4 | TECH |
BIO-TECHNE Corp
|
67,227 | $4,749,587 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
60,348 | $4,723,437 | |
| 6 | VKTX |
Viking Therapeutics, Inc.
|
90,546 | $3,532,199 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
7,880 | $2,372,116 | |
| 8 | TRVI |
Trevi Therapeutics, Inc.
|
106,852 | $1,992,789 |
All Filings in EXEL
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,431,967 | 99,834 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $244,473 | 5,700 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $7,382,593 | 168,437 | Shares | Sole | 2026-02-11 | |
| 2025-06-30 | $1,942,341 | 44,064 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,289,521 | 197,441 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,316,548 | 39,536 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $6,976,735 | 268,853 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,001,802 | 44,584 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $1,056,174 | 44,508 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $534,689 | 22,288 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $503,271 | 23,033 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $472,628 | 24,732 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,215,560 | 217,185 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,932,673 | 182,835 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,293,889 | 146,294 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $2,936,473 | 141,041 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $1,503,497 | 66,321 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $1,165,148 | 63,739 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $1,132,723 | 53,582 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $969,376 | 53,204 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $1,327,139 | 58,749 | Shares | Sole | 2021-07-21 | |
| 2020-12-31 | $1,482,751 | 73,879 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $5,726,556 | 234,215 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $5,290,530 | 222,853 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $8,324,509 | 483,421 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||